Document Type : original article

Authors

Children and Adolescents Health research center, Research Institute of cellular and Molecular Science in Infectious Diseases, Zahedan University of Medical Science's, Zahedan, Iran

Abstract

Background: Diabetes mellitus type I (DMT1) is a highlighted endocrine and digestive issue that involves the heart organs; with more effect when lipids profiles are considered. The study aimed to assess the variations in echocardiographic findings due to the changes in lipids profiles among children with DMT1.
Methods: This case-control study was performed on 96 DMT1 and 96 healthy children. The DMT1 was confirmed by clinical manifestations and laboratory measures. Both groups underwent conventional echocardiography and HbA1c; diabetic duration and lipids profiles were measured for the children with diabetes. Data was analyzed via SPSS 18.0 and P < 0.05 was considered as the significance level.
Results: It was found that the left MPI was higher in patients (p=0.001) than in healthy controls. Patients with poor control had higher levels of LVMI and left deceleration time (p<0.05) compared to optimal controls. Patients with abnormal CHO had higher ejection fraction, fraction of shortening, Left E/A, LAd/Aod, LAs/Aos, left ejection time and PWD while right deceleration time, Aortic diameter in diastole, aortic diameter in systole, left MPI and left deceleration time had lower levels.  LDL changes affected aorta diameter in diastole, right deceleration time, aorta diameter in systole, left MPI and left deceleration time, fractional shortening, Left E/A, LAd / Aod, LAs/Aos, aortic ejection time and PWD. Patients with an abnormal HDL, had higher left MPI and lower left ejection time.
Conclusion: It was concluded that more conventional echocardiography involvement is observed in DMT1 children who have abnormal lipids profiles as well as abnormal HbA1c and longer diabetes durations.

Keywords

1- INTRODUCTION

Diabetes Mellitus Type I (DMT1) is a highlighted endocrine and digestion issue (1) and is an insusceptible framework affliction with a solid hereditary part including all ages and races (2) specially children (3). The frequency of Diabetes Mellitus (DM) is evaluated as 387 million people that DMT1 accounted for 5-10% of it, in different areas (4). In Iran, the prevalence extended from 7.7% in 2005 to 8.7% in 2007 and it is proceeding due to issues such as financial weight, lifestyle changes and social protection (5). A strong association exists between DM and Cardiovascular Diseases (CVD) with a predominant reason for mortality (6). CVD death rate in diabetic patients tends to be about twice as much as that of non-diabetic (7) and DM patients with extreme lipids profiles being more at risk in contrast to those with typical lipids profiles. In this regard, Noori et al. (8) revealed that children with DMT1 who had high low-thickness lipoproteins (LDL) cholesterol are most at CVD hazard compared to those with low LDL. Thus, it appears to be essential to focus on lipids variations from the norm so as to diminish cardiovascular disorders at early ages (7).  Lipids abnormality, more observed in diabetes patients with poor control, indicated an ordinary level or marginally diminished triglycerides and LDL-cholesterol level. In addition, expanded HDL cholesterol levels decline the danger of CVD (9). In spite of the fact that, the specific results of these changes on the improvement of cardiovascular diseases in diabetes are yet obscure, subjective anomalies of lipoproteins are observed in patients with type I diabetes, even in good glycemic control and these variations from the norm are not completely clarified by hyperglycemia and may be due to the marginal hyperinsulinemia related to the internal course of insulin organization (1). Echocardiography is a basic symptomatic tool and method to show heart utilitarian oddities in chronic diseases such as; thalassemia, diabetes and celiac. The most notable method is the conventional echocardiography which has offered improved quality pictures, and has extended the affectability of echocardiography on the disclosure of subclinical ventricular complications (8). Along these lines, the present examination is expected to survey the progress in regular echocardiographic findings due to changes in lipids profiles in children with DMT1.

2- MATERIALS AND METHODS

2-1. Study design

This case-control study performed on192 children, including 96 healthy and 96 with diabetes mellitus type I. The investigation was conducted in Ali Asghar Pediatric Hospital, Zahedan, the capital city of Sistan & Baluchestan province, Iran. The examination was run in two centers in collaboration with endocrinology and cardiology between March 2018 and April 2019.

2.2- Sampling

Sample size was calculated from the following formula;

Where, Zα=1.96, Zβ=0.84 and r =1. For the parameters of Myocardial Performance Index (MPI), the mean value extracted was 0.29 and 0.27 for the patients and controls, respectively (10). Utilizing the referenced parameters in the mentioned equation gave us 96 subjects in each group.

2-3. Inclusion and Exclusion Criteria

DMT1 patients either symptomatic or asymptomatic were included in the study. The disease of diabetes was confirmed by the clinical manifestations such as polyuria, polydipsia and weight loss along with the laboratory measures such as fasting blood glucose > 125, random blood glucose>200 mg/dl. Exclusion criteria were the ages higher than 18 years, documented evidence of other cardiac diseases like cardiomyopathy, valvular heart disease, congenital heart disease, and myocarditis, as well as the features of hypothyroidism, uremia, and random blood sugar > 140 mg/dL for both groups.

2-4. Measurements

2-4.1. Echocardiography measures

Both groups went under conventional echocardiography (M mode and 2D) by a cardiologist, using My Lab 60 instrument with 3-8-MHz transducers (made in Italy). The values of all necessary echocardiographic parameters, namely Ejection Fraction (EF), Fractional Shortening (FS), velocity of the blood flow through the heart valves, as well as the Ejection Time (ET), peak A velocity (A), peak E velocity (E), Myocardial Performance Index (MPI), peak E (early mitral and tricuspid valve flow velocity) /peak A (late mitral and tricuspid valve flow velocity) velocity (E/A ratio), isovolumic relaxation time (IVRT), Isovolumic Contraction Time (ICT) of both sides were measured with pulsed Doppler echocardiography. The sample volume was positioned at the tips of the tricuspid and mitral valve leaflets in the apical four chamber view to enable the measurement of (a): the time interval between the start and the end of trans-mitral and trans tricuspid flow. The sample volume was thereafter relocated to the left ventricular outflow tract just below the aortic valve (apical five-chamber view) so as to measure (b): the left ventricular ejection time. The right ventricular outflow velocity pattern was also recorded from the parasternal short-axis view with the Doppler sample volume positioned just distal to the pulmonary valve for the measurement of (b). Myocardial Performance Index (MPI/Tei Index) was calculated as a-b/b = (ICT + IRT)/ET (11). The left ventricular mass index (LVMI) was calculated by the following formula: LVM (g) = 0.8 (1.04 (((LVDD + PWD + IVSD)3 -LVDD 3))) + 0.6; and LVMI (g/m2) = LVM / 2.7 (11) and relative wall thickness was also calculated from RWT = 2 PWD/ LVDD formulae.

2-4.2. Lipids profiles

Patients were tested for their lipids profiles of cholesterol (CHO) mg/dl, high density lipoprotein (HDL) mg/dl, low density lipoprotein (LDL) mg/dl, and triglyceride (TG) mg/dl. Abnormal lipids profile was defined as CHO >200 mg/dl, HDL < 40 mg/dl, LDL >130 mg/dl, and TG >150 mg/dl (1).

2-4.3. Diabetic measures and duration of diabetic state

The cardiac functions in our patients were categorized based on hemoglobin A1c (HbA1c) and duration of diabetic state.

  1. a) HbA1c:

The level of HbA1c reflects glycemic control. HbA1c is the mean blood glucose concentration during the 3 months preceding the measurement. Higher values indicate higher blood glucose levels, and therefore, more poorly controlled diabetes. Laboratory results of HbA1c assays in the blood samples are conducted as part of the patients’ regular outpatient visit. The normal range on this assay is 4.0-6.1%. For the purposes of this study, we considered good control to be an HbA1c < 7%, and poor control to be an HbA1c ≥ 7%. (11).

  1. b) Duration of the diabetic state

The diabetic duration is considered as the time between the disease onset based on the diagnosed time by the pediatric endocrinologist and the time of referring to the pediatric cardiologist for performing conventional echocardiography.

The patients were classified into groups according to their diabetic duration based on the cut point of 4 years.

2-4.4. Anthropometric measurements

The height and weight of children were measured by an experienced expert using the standard equipment. The recumbent length for children under 2 years were graded using a flat wooden table; and their weight measurements were performed by the use of the balance weights Mika with the error probability of 100gr, and then their BMIs were calculated [Weight (Kg) / Height (m²)].

2-5. Ethical Considerations

Informed consent was obtained from all individual participants included in the study after the study approval. The study was approved as a project proposed (ID-code: 7230) to the Children and Adolescent Health Research Center by the Ethics Committee of Zahedan University of Medical Sciences, Zahedan, Iran.

2-6. Statistical Analysis

Data was analyzed via SPSS 18.0 (SPSS Inc, Chicago, IL, USA). Descriptive statistics were presented in mean ±SD. Comparisons between DMT1 subjects and the controls were performed using t-test and Mann-Whitney U test; and when more than two groups were to be compared, the One-way Analysis of Variance and Kruskal –Wallis tests were used based on normality of the variable data distribution. The correlations between the variables were calculated using Pearson’s correlation. P < 0.05 was considered significant.

3- RESULTS

The study was conducted on 192 subjects composed equally of diabetic and healthy children. The children had a sex distribution of 52.6% and 47.4% for boys and girls, respectively.  From among the patients, 47.9% were boys when this rate was 57.3% for controls with similar sex distribution in patients and controls (X2=1.692, p= 0.193). Mean age of the participants was 10.82± 3.15 years, such that the patients and controls had 10.87±3.46 and 10.77±2.82 years, respectively.

Table 1 demonstrates the normality distribution of study variables among the participants. Table 2 shows that the right and Left DT, (p<0.001), aorta diameter in diastole (p=0.005) and aorta diameter in systole (p=0.011) were higher in patients when ET (p<0.001), EF (p<0.021), left E/A (p=0.019), LAs /Aos (p=0.001), FS (p=0.014) were higher in controls. MPI was significantly higher in the patients (p=0.001).

Table 3 shows the comparisons between the study variables in diabetic children based on HbA1C groups (cut off point= 7%).  Patients with poorly controlled glucose had higher levels in LVMI and left DT significantly (p<0.05).

Table 4 presents the comparisons based on the diabetes duration. In children with longer period diabetes, HbA1c was significantly higher (p=0.008), LA diameter in systole / aortic diameter in systole was significantly lower (p=0.042), LVMI significantly decreased (p=0.005), right AT significantly increased (p=0.047), IVSD significantly decreased (p=0.028), PWD significantly decreased (p=0.036), and right E/A decreased significantly (p=0.050).

Table 5 shows the comparisons based on CHO changes in diabetic children.  The changes of CHO were based on the level of 200 mg/dl, in which the normal patients had < 200mg/dl of CHO. In patients with abnormal CHO EF (p=0.015), the levels of FS (p=0.014), Left E/A(p=0.024), LAd/Aod(p=0.008), LAs/Aos(p=0.001), left ET (p<0.001), and PWD(p=0.039) were higher and the echocardiography findings of the right deceleration time(p<0.001), aortic diameter in diastole(p=0.002), aortic diameter in systole (p=0.013), Left MPI (p=0.001) and left DT(P,0.001) were lower, significantly.  Regarding the lipids profile changes, LDL and HDL both increased in patients with an abnormal status of CHO (p<0.05).

Table 6 compares the cardiac findings based on LDL changes in diabetic children. LDL > 130 mg/dl was considered abnormal. In patients who had abnormal values of LDL, the aorta diameter in diastole (p=0.002), right DT (p<0.001), and aorta diameter in systole (p=0.010) were significantly lower. However, the ejection fraction (p=0.010) and fractional shortening (p=0.009) were higher in patients with abnormal LDL values, left MPI (p=0.001) was lower, Left E/A (p=0.026) and LAd / Aod (p=0.017) were higher, LAs/Aos (p=0.001) ,  left ejection time (p<0.001) and PWD(p=0.047) were higher; and in final, the left deceleration time (p<0.001) was lower, significantly.  The lipids profile of HDL increased in patients with an abnormal status of LDL (p<0.001).  The results indicated that the echocardiography findings did not change by TG variation in the patients but the CHO increased in patients with an abnormal status of TG levels (p<0.001). Those patients who had abnormal values of HDL, had higher left MPI (p=0.023) when left ejection time (p=0.015) was lower in patients with abnormal HDL. TG increased in patients with a normal status of HDL (p<0.001).

4- DISCUSSION

The results of the study revealed that he left DT, aorta diameter in diastole and aorta diameter in systole were higher in patients, while ET, EF, left E/A, LAs /Aos, and FS were higher in controls. The left MPI was also higher in patients. Patients with poor glycemic control had higher LVMI and left DT. Children with longer periods of diabetes had an increase in HbA1c, right AT, and a decrease in LA diameter in systole / aortic diameter in systole, LVMI, IVSD, PWD, and right E/A. The results also indicated that patients with an abnormal status of CHO, had higher values  of EF, while their FS, left E/A, LAd/Aod, LAs/Aos, left ET, PWD and right DT, aortic diameter in diastole, aortic diameter in systole, Left MPI and left DT had lower values. In addition, the LDL and HDL both increased in patients with an abnormal status of CHO. The diabetic children with an abnormal LDL had lower AoD, right DT, AoS, and left MPI and left DT, while the parameters of EF, ES, left E/A, Lad/Aod, LAs/Aos, left ET, PWD and RWT had higher values. The echocardiography findings did not change by TG variation. The patients with abnormal values of HDL, had higher left MPI while their left ET was lower.

The diabetes cardiomyopathy is defined as the cardiovascular damage in diabetic patients, which is characterized by myocardial dilatation and hypertrophy, as well as a decrease in the systolic and diastolic functions of the left ventricle, and its presence is independent of the coexistence of ischemic heart disease or hypertension (12).  DMT1 predicts a broad range of later health problems including an increased risk of cardiovascular morbidity and mortality; and may even begin in childhood (13). Nonetheless, Ferranti et al. (14) expected that cardiac disorders do not occur during childhood, even in the setting of DMT1 with lipids profile abnormalities.  Atabek et al. (13) reported that the total cholesterol, triglycerides and LDL-cholesterol were slightly higher in diabetic children than in healthy controls. Endogenous insulin production reduces vascular complications and improves glucose control that may have a beneficial effect on CVD risk in the long period due to a favorable lipids profile. As children enter into adolescence, increasing the good glycemic control may lead to improvements in lipids levels (15), such that the risk of CVD will decrease (13).

Noori et al. (11) conducted a study on cardiac functions in diabetic children. They found that the left and right DTs were higher in patients, and the left and right peak E velocity were lower; the left ET decreased in patients and left MPI increased.

 

 

Table-1: Test of normality of the study variables in the participants

All Participants

Diabetes Patients

Variables

Mean

SD

K.S

P

Mean

SD

K.S

P

Age

10.82

3.15

0.068

0.03

10.87

3.46

0.128

<0.001

Height

145.5

18.02

0.086

0.001

137.45

19

0.074

0.200

Weight

38.78

13.24

0.083

0.003

33.24

11.78

0.076

0.200

Left AT

58.82

8.9

0.157

<0.001

58.64

9.25

0.159

<0.001

Left DT

156.7

45.58

0.107

<0.001

177.6

51.32

0.114

0.003

Right AT

62.28

10.34

0.159

<0.001

62.77

11.17

0.136

<0.001

Right DT

145.38

38.22

0.103

<0.001

162.3

40.96

0.081

0.132

Aod

2.06

0.32

0.098

<0.001

2.13

0.32

0.074

0.200

LAd

2.29

0.37

0.068

0.03

2.31

0.39

0.091

0.048

Aos

1.91

0.31

0.053

0.2

1.97

0.29

0.056

0.200

LAs

1.5

0.29

0.073

0.014

1.48

0.31

0.074

0.200

Left ET

248.57

32.47

0.154

<0.001

240.53

25.61

0.116

0.003

IVSD

0.67

0.13

0.132

<0.001

0.68

0.14

0.132

<0.001

LVDD

3.82

0.46

0.057

0.2

3.8

0.45

0.052

0.200

PWD

0.35

0.06

0.135

<0.001

0.35

0.06

0.139

<0.001

IVSS

0.85

0.15

0.115

<0.001

0.87

0.16

0.135

<0.001

LVDS

2.1

0.32

0.072

0.016

2.12

0.33

0.053

0.200

PWS

0.36

0.05

0.137

<0.001

0.35

0.06

0.136

<0.001

EF

76.57

5.46

0.089

0.001

75.63

5.86

0.083

0.107

FS

44.92

5.06

0.057

0.2

44.03

5.34

0.086

0.079

RWT

0.19

0.09

0.25

<0.001

0.18

0.03

0.12

0.002

Left  E / A

1.87

0.46

0.085

0.002

1.78

0.41

0.075

0.200

Right E / A

1.44

0.35

0.116

<0.001

1.4

0.32

0.154

<0.001

Lad / Aod

1.12

0.17

0.063

0.062

1.1

0.17

0.078

0.182

Las / AoS

0.8

0.16

0.084

0.002

0.76

0.16

0.079

0.159

Right ET

255.89

25.91

0.090

0.001

253.98

26.53

0.078

0.183

Left MPI

0.69

0.18

0.042

0.200

0.7374

0.16

0.080

0.153

Right MPI

0.69

0.16

0.076

0.009

0.6794

0.17

0.067

0.200

LVMI

28.9

9.65

0.089

0.001

29.04

10.05

0.09

0.053

Diabetes duration

 

 

 

 

31.34

23.7

0.174

<0.001

Hb A1c

 

 

 

 

8.49

2.12

0.112

0.005

TG

 

 

 

 

124.52

76.17

0.175

<0.001

CHO

 

 

 

 

155.54

37.52

0.116

0.004

LDL

 

 

 

 

90.61

23.93

0.212

<0.001

HDL

 

 

 

 

54.23

11.91

0.17

<0.001

 

 

Table-2: Comparing the study variables between the children with Diabetes type I and the controls

Variables

Groups

Mean

SD

Test Value

P value

Variables

Mean

SD

Test Value

P value

Height

Case

137.45

19.00

2362.000

<0.001

LVDS

2.12

0.33

4141.000

0.225

Control

153.55

12.68

2.07

0.31

 

Weight

Case

33.24

11.78

2416.500

<0.001

PWS

0.35

0.06

4225.500

0.318

Control

44.31

12.31

0.36

0.05

 

Left AT

Case

58.64

9.25

4493.500

0.761

EF

75.63

5.86

3723.500

0.021

Control

59.01

8.58

77.51

4.87

 

Left DT

Case

177.60

51.32

1768.500

<0.001

RWT

0.18

0.03

4247.000

0.348

Control

135.79

25.67

0.20

0.12

 

Right AT

Case

62.77

11.17

4314.000

0.438

Left E/A

1.78

0.41

3701.500

0.019

Control

61.79

9.48

1.96

0.49

 

Right DT

Case

162.30

40.96

2011.000

<0.001

Right E/A

1.40

0.32

4093.500

0.181

Control

128.45

26.08

1.49

0.38

 

Right ET

Case

253.98

26.53

4489.500

0.757

LAs/Aos

0.76

0.16

3384.500

0.001

Control

257.79

25.28

0.83

0.15

 

Aod

Case

2.13

0.32

3517.500

0.005

Right MPI

0.68

0.169

4442.000

0.666

Control

2.00

0.30

0.69

0.153

 

LAd

Case

2.31

0.39

4265.000

0.373

LVMI

29.04

10.05

4558.000

0.897

Control

2.26

0.35

28.77

9.28

 

LAs

Case

1.48

0.31

4218.500

0.311

Aos

1.97

0.29

2.571

0.011

Control

1.52

0.26

1.85

0.31

2.571

Left  ET

Case

240.53

25.61

3187.000

<0.001

LVDD

3.80

0.45

-0.447

0.655

Control

256.60

36.52

3.83

0.48

 

IVSD

Case

0.68

0.14

4302.500

0.426

FS

44.03

5.34

-2.469

0.014

Control

0.66

0.11

45.81

4.63

 

PWD

Case

0.35

0.06

4092.000

0.178

LAd/Aod

1.10

0.17

-1.961

0.051

Control

0.36

0.05

1.15

0.17

 

IVSS

Case

0.87

0.16

3999.000

0.113

Left MPI

0.74

0.163

3.473

0.001

Control

0.82

0.15

0.65

0.180

3.473

 

 

 

Table-3: comparing the study variables between the two groups of children with Diabetes type I; Good (45 children) and poor control (51 children)

Variables

Hb A1c (7%)

Mean

SD

Test value

P value

Variables

Mean

SD

Test value

P value

Height

Normal

134.3

18.39

-1.399

0.165

LAs/Aos

0.76

0.14

0.198

0.482

Abnormal

139.73

19.26

0.76

0.18

Weight

Normal

31.3

11.09

-1.386

0.169

LVMI

26.79

8.2

-2.09

0.039

Abnormal

34.63

12.18

31.06

11.19

Right dt

Normal

154.36

40.91

-1.922

0.058

Left AT

58.77

9.55

1067.5

0.679

Abnormal

170.25

39.57

 

58.47

9.16

Aod

Normal

2.07

0.32

-1.758

0.082

Left DT

167.86

48.05

848.5

0.041

Abnormal

2.18

0.32

186.76

53.11

Aos

Normal

1.96

0.28

-0.205

0.838

Right AT

63.2

12.64

1095

0.838

Abnormal

1.97

0.3

62.76

9.62

LAs

Normal

1.49

0.28

0.109

0.913

Right ET

252

26.28

1064.5

0.667

Abnormal

1.48

0.34

255.88

27.09

LVDD

Normal

3.73

0.39

-1.336

0.185

LAd

2.32

0.36

1094

0.834

Abnormal

3.86

0.5

2.31

0.42

LVDS

Normal

2.11

0.3

-0.47

0.64

Left ET

238.77

32.73

1070

0.697

Abnormal

2.14

0.36

241.86

17.86

EF

Normal

75.16

5.55

-0.66

0.511

IVSD

0.65

0.13

892.5

0.086

Abnormal

75.96

6.18

0.7

0.15

FS

Normal

43.43

4.79

-0.96

0.34

PWD

0.34

0.06

994

0.336

Abnormal

44.49

5.81

0.36

0.06

Left MPI

Normal

0.75

0.17

0.599

0.55

IVSS

0.86

0.14

1041.5

0.547

Abnormal

0.73

0.15

0.88

0.17

Right MPI

Normal

0.68

0.14

0.169

0.866

PWS

0.35

0.06

980.5

0.288

Abnormal

0.67

0.19

0.36

0.06

Left E/A

Normal

1.72

0.44

-1.154

0.251

RWTI

0.18

0.04

1050.5

0.594

Abnormal

1.82

0.37

0.19

0.03

LAd/Aod

Normal

1.13

0.14

1.834

0.07

RE.A

1.37

0.28

1008

0.395

Abnormal

1.07

0.19

1.44

0.34

Age

Normal

10.11

3.48

824.00

0.026

LDL

159.26

42.20

954.50

0.352

Abnormal

11.61

3.29

152.34

33.09

Duration

Normal

35.43

22.51

896.50

0.091

HDL

93.56

26.62

903.50

0.185

Abnormal

28.43

24.25

88.08

21.30

CHO

Normal

136.86

88.01

978.00

0.454

TG

54.53

11.07

968.00

0.501

Abnormal

113.90

63.27

53.96

12.71

 

 

Table-4: comparing the study variables in children with Diabetes type I based on Duration of diabetes

Variables

Duration

(years)

Mean

SD

Test Value

P value

Variables

Mean

SD

Test Value

P value

Height

<4

143.50

20.42

1.065

0.29

LAs/Aos

0.86

0.22

2.061

0.042

>=4

136.74

18.83

0.75

0.15

Weight

<4

37.70

13.03

1.269

0.208

LVMI

37.31

11.42

2.85

0.005

>=4

32.72

11.60

28.08

9.5

Right DT

<4

163.80

41.97

0.122

0.904

Left AT

53.4

8.92

280

0.067

 

>=4

162.13

41.09

0.12

0.907

59.24

9.14

Aod

<4

2.11

0.24

-0.176

0.861

Left DT

165

83.51

340.5

0.282

>=4

2.13

0.33

179.07

46.74

Aos

<4

1.88

0.26

-1.006

0.317

 Right AT

56

8.86

266.5

0.047

>=4

1.98

0.29

63.56

11.19

LAs

<4

1.60

0.41

1.297

0.198

Right ET

256

30.64

390

0.631

>=4

1.46

0.30

253.74

26.2

LVDD

<4

3.97

0.44

1.263

0.21

LAd

2.34

0.34

400.5

0.723

>=4

3.78

0.45

2.31

0.4

LVDS

<4

2.29

0.30

1.651

0.102

Left ET

234.9

21.98

358

0.386

>=4

2.11

0.33

241.19

26.04

EF

<4

74.10

4.56

-0.868

0.388

IVSD

0.8

0.18

247.5

0.028

>=4

75.80

5.99

0.67

0.13

FS

<4

42.50

4.14

-0.958

0.341

PWD

0.4

0.08

256.5

0.036

>=4

44.21

5.45

0.34

0.06

Left MPI

<4

0.71

0.14

-0.553

0.582

IVSS

0.97

0.2

296.5

0.109

>=4

0.74

0.17

0.86

0.15

Right MPI

<4

0.63

0.18

-1.031

0.305

PWS

0.4

0.08

271.5

0.056

>=4

0.69

0.17

0.35

0.05

Left E/A

<4

1.77

0.42

-0.052

0.959

RWT

0.2

0.04

284.5

0.081

>=4

1.78

0.41

0.18

0.03

LAd/Aod

<4

1.11

0.14

0.275

0.784

Right E/A

1.55

0.36

266.5

0.05

>=4

1.10

0.18

1.39

0.31

Age

<4

10.77

2.96

425

0.952

LDL

138.5

33.03

222

0.105

>=4

10.87

3.38

157.14

37.7

HbA1c

<4

0.93

3.13

209.5

0.008

HDL

95.13

24.35

326

0.847

>=4

8.33

1.72

90.19

23.99

CHO

<4

104.38

53.01

314

0.721

TG

51.14

9.49

268

0.662

>=4

126.41

77.96

54.48

12.1

 

 

Table-5: Comparing the study variables between the type I diabetic children with normal and abnormal CHO

Variables

CHO

Groups

Mean

Std. Deviation

Test Value

P value

Variables

Mean

Std. Deviation

Test Value

P value

Height

Normal

137.56

18.69

-5.98

0

LAs/Aos

0.76

0.16

-3.24

0.001

Abnormal

151.94

14.64

0.83

0.15

Weight

Normal

33.15

11.58

-5.73

0

LVMI

28.72

9.97

-0.24

0.811

Abnormal

43.34

12.78

29.05

9.43

Right DT

Normal

164.38

41.58

6.93

0

Left AT

58.58

9.54

4460

0.794

Abnormal

129.95

26.86

59.02

8.39

Aod

Normal

2.14

0.33

3.14

0.002

Left DT

181.57

51.33

1558.5

<0.001

Abnormal

2

0.3

136.52

26.97

Aos

Normal

1.97

0.29

2.5

0.013

Right AT

63.15

11.5

4160

0.291

Abnormal

1.86

0.31

61.58

9.3

LAs

Normal

1.48

0.32

-1.07

0.284

Right ET

254.78

27.54

4449.5

0.776

Abnormal

1.52

0.26

256.78

24.61

LVDD

Normal

3.8

0.44

-0.42

0.672

LAd

2.3

0.4

4385.5

0.652

Abnormal

3.83

0.48

2.28

0.34

LVDS

Normal

2.13

0.33

1.06

0.29

Left ET

240.05

25.85

3122

<0.001

Abnormal

2.08

0.31

255.48

35.63

EF

Normal

75.51

5.99

-2.45

0.015

IVSD

0.67

0.14

4474

0.826

Abnormal

77.42

4.85

0.66

0.11

FS

Normal

43.93

5.46

-2.48

0.014

PWD

0.34

0.06

3773.5

0.039

Abnormal

45.73

4.59

0.36

0.05

Left MPI

Normal

0.74

0.16

3.48

0.001

IVSS

0.87

0.15

4107

0.238

Abnormal

0.66

0.18

0.83

0.15

Right MPI

Normal

0.68

0.17

-0.64

0.524

PWS

0.35

0.06

3930.5

0.099

Abnormal

0.69

0.15

0.36

0.05

Left E/A

Normal

1.78

0.42

-2.28

0.024

RWT

0.18

0.03

3932.5

0.102

Abnormal

1.93

0.48

0.20

0.12

LAd.Aod

Normal

1.08

0.17

-2.69

0.008

Right E/A

1.42

0.32

4412.50

0.704

Abnormal

1.15

0.17

1.46

0.37

Age

Normal

10.9488

3.36038

386.00

0.60

LDL

149.40

30.66

0.00

<0.001

Abnormal

10.1500

4.38463

231.00

33.00

HbA1c

Normal

8.5302

1.90251

422.50

0.928

HDL

85.91

16.97

10.50

<0.001

Abnormal

8.1000

3.58484

148.43

21.99

Duration

Normal

31.5349

23.46045

391.50

0.643

TG

53.73

11.50

210.50

0.197

Abnormal

29.7000

26.94047

60.29

15.92

 

 

 

Table-6: Comparing the study variables between the type I diabetic children with normal and abnormal LDL

Variables

LDL

group

Mean

Std. Deviation

Test Value

P value

Variables

Mean

Std. Deviation

Test Value

P value

Height

Normal

137.55

18.71

-5.99

<0.001

Las/Aos

0.76

0.16

-3.23

0.001

Abnormal

151.95

14.61

0.83

0.15

Weight

Normal

33.15

11.58

-5.73

<0.001

LVMI

28.77

9.94

-0.18

0.858

Abnormal

43.34

12.78

29.02

9.45

Aod

Normal

2.14

0.33

3.17

0.002

Left AT

58.85

9.44

4317

0.521

Abnormal

2

0.3

58.8

8.48

Right DT

Normal

163.86

41.83

6.69

<0.001

Left DT

181.13

51.82

1632

<0.001

Abnormal

130.38

27.09

136.88

26.81

Aos

Normal

1.97

0.28

2.59

0.01

Right AT

63.15

11.5

4160

0.291

Abnormal

1.86

0.32

61.58

9.3

LAs

Normal

1.48

0.32

-0.99

0.325

Right ET

254.84

27.55

4435

0.747

Abnormal

1.52

0.26

256.74

24.61

LVDD

Normal

3.81

0.44

-0.35

0.725

LAd

2.31

0.4

4272.5

0.456

Abnormal

3.83

0.48

2.27

0.34

LVDS

Normal

2.13

0.33

1.2

0.233

Left ET

240.17

25.82

3149.5

<0.001

Abnormal

2.07

0.31

255.38

35.69

EF

Normal

75.45

5.96

-2.59

0.01

IVSD

0.67

0.14

4452.5

0.782

Abnormal

77.47

4.86

0.66

0.11

FS

Normal

43.87

5.43

-2.63

0.009

PWD

0.34

0.06

3801

0.047

Abnormal

45.77

4.6

0.36

0.05

Left MPI

Normal

0.74

0.16

3.42

0.001

IVSS

0.87

0.15

4101

0.232

Abnormal

0.66

0.18

0.83

0.15

Right MPI

Normal

0.68

0.17

-0.78

0.435

PWS

0.35

0.06

3959

0.116

Abnormal

0.69

0.15

0.36

0.05

Left E / A

Normal

1.79

0.42

-2.24

0.026

RWT

0.18

0.03

3929.5

0.101

Abnormal

1.93

0.48

0.2

0.12

LAd /Aod

Normal

1.09

0.17

-2.41

0.017

Right E/A

1.42

0.32

4295.5

0.493

Abnormal

1.15

0.17

1.47

0.37

Age

Normal

10.98

3.31

367

0.448

CHO

124.45

72.15

258.00

0.531

Abnormal

9.85

4.64

125.29

123.29

HbA1c

Normal

8.52

1.88

426

0.962

HDL

85.36

15.51

0.00

0.000

Abnormal

8.20

3.72

155.14

10.90

Duration

Normal

31.80

23.24

349.5

0.332

TG

53.93

11.50

263.50

0.614

Abnormal

27.40

28.42

57.86

16.89

 

 

 

Ozdemir et al. (16) found that the left and right MPI were higher, and LV, RV and ET were lower in children with diabetes.  Abd-El Aziz et al. (10) evaluated the cardiac functions in children with diabetes and concluded that the diameter of aorta, left LA, IVSS, LVPW, LVDD and LVDs were higher, while FS was lower. They also demonstrated that the patients had lower E and A wave velocity in right and left. All these results confirmed the findings of the present study.

Our findings also manifested that the diabetic children with an increase in Hb A1c had higher levels in LVMI and left deceleration time but none of their lipids profiles changed. In the same line, M Abd-El Aziz et al. (10) categorized diabetic patients based on HbA1c status (good and poor control) and concluded that all conventional parameters were similar.  Mehravar et al. (17) also confirmed the correlation between HbA1c and cholesterol, TC, LDL and HDL ratio.  In a study by Mostofizadeh et al. (18), dyslipidemia was presented as high as 74.8% among Iranian children with diabetes.  The most common lipids profile abnormality in their study was hypercholesterolemia followed by high LDL. Furthermore, the patients with poorly controlled glucose had a significantly higher LDL in comparison to the well-controlled patients.  The inconsistency of their results with that of the present study might be due to age of the patients. In addition, it may be partly explained by the fact that a single HbA1c may not reflect the overall control of diabetes and might cause insufficient and deceptive information about long-term glycemic control. So, the mean HbA1c value averaged from several time measures instead of a single instantaneous value can provide more accurate information about glycemic control. Rexhepi et al. (19) grouped the diabetic patients in controlled and uncontrolled diabetic dyslipidemia. After comparing some cardiac findings between these two groups, they found no differences between the groups in relation of left ventricular dimensions, the thickness of left ventricular septum and posterior wall, EF, FS, and LVM. The present study revealed that children with longer periods of diabetes had lower LAs / Aos, LVMI, IVSD, PWD and right E/A and had a higher right acceleration time.  Moreover, any of the lipids profiles did not change in duration; though the level of HbA1c was higher in patients with longer durations. In the study by Aderibigbe et al. (21), inconsistent with our findings, a marked decrease was found in the percentage of subjects showing high levels of CHOL, LDL and triglyceride after receiving treatment for 7 years when compared to those who had received treatment for less than 7 years. The dissimilarity might be due to the difference in the time duration considered for the groupings. In this regard, Abd-El Aziz et al. (10) found no significant correlation between the duration of diabetes and the conventional echocardiography findings. However, we found significant changes in some of the parameters including  LA diameter in systole / aortic diameter in systole, LVMI, IVSD, PWD, right E/A, and right acceleration. Abd-El Aziz et al. (10) compared the conventional echocardiography findings between the patients with and without dyslipidemia. They revealed that all the conventional findings were similar except for the left peak a velocity. We, recently, conducted a similar study on Doppler tissue imaging findings (1) and found that the left ICT’ and right S’ were higher in the abnormal status of HBA1c.  All TDI findings were similar in patients with short and long duration. Patients with higher TG had lower values of left A/A’. The patients with abnormal cholesterol had higher right S’, right E’ and right A’ but had lower right E/E’. Right S’ was higher in DMT1 children with abnormal LDLs while their right E/E’ was lower. Any of the DTI findings did not change in line with the HDL changes. Dyslipidemia can serve as an early biomarker for cardiovascular dysfunction in children with TDM1.

4.1- Study limitation

The main limitation of the study was the lack of proper cooperation on the part of the participants, especially the controls.

5- CONCLUSION

In general, the findings demonstrated that the type I diabetes mellitus children with uncontrolled Hb A1c had higher levels in LVMI and left deceleration; furthermore the LA / Ao diameter in systole were lower in and LVMI, IVSD, PWD and right E/A and right acceleration time were higher when the duration of diabetes increased.   The present study revealed that the damage of heart function in systole and diastole such as MPI, ejection fraction and fractional shortening changed by lipids profiles of cholesterol, low-density lipoprotein and high-density lipoprotein when triglyceride changes did not affect the cardiac functions. Therefore, in children with DMT1, the lipid profile have different effects on the conventional echocardiography finding, especially in respect to the systolic and diastolic parameters.

6- ACKNOWLEDGEMENTS

The authors would like to present their deep thanks to the parents of children for their participation in the study.

7- CONFLICT OF INTEREST

The authors would like to declare for no conflict of interest.

8- ABBREVIATIONS

AT: Acceleration Time, DT: Deceleration Time, Aod: Diameter of Aorta in Diastole, LAd: Diameter of LA in Diastole, Aos: Diameter of Aorta in Systole, LAs: Diameter of LA in Systole, ET: Ejection Time, IVSD: Interventricular Septal Dimension in Diastole, LVDD: Left Ventricular end-Diastolic Dimension, PWD: Posterior Wall Dimension in diastole, IVSS: Interventricular Septal dimension  in Systole, LVDS: Left Ventricular end-Systolic Dimension, PWS: Posterior Wall dimension in Systole, EF: Ejection Fraction (calculated in the apical two and four chamber views with Simpson’s apical biplane method), FS: Fractional Shortening, RWT: Relative Wall Thickness, E: peak E velocity, A:  peak A velocity, MPI: Myocardial Performance Index, LVMI: Left Ventricular Mass Index,  TG: Triglycerides  , CHO: Cholesterol, LDL: Low-Density Lipoprotein  , HDL: High-Density Lipoprotein. 

9- AUTHORS’ CONTRIBUTION

Noori designed the study; Teimouri analyzed the data; Noori, Nakhaee and Teimouri wrote the primary version of the manuscript. All Authors agree for the publication of the present manuscript.

  1. Noori N, Nakhaee-Moghadam M, Teimouri A, Bagheri H. Tissue Doppler Imaging Findings and Lipids Profile Changes in Diabetes Mellitus Type I Children. International Journal of Pediatrics. 2019 Dec 1; 7 (12):10423-39.
  2. Noble JA, Erlich HA. Genetics of type I diabetes. Cold Spring Harb Perspect Med 2012; 2:1–15.
  3. Steck AK, Rewers MJ. Genetics of type I diabetes. Clin Chem 2011; 57:176–85.
  4. You WP, Henneberg M. Type I diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. BMJ Open Diabetes Research and Care. 2016 Mar 1; 4(1):e000161.
  5. Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, Asgari F, Mousavizadeh M, Rafei A, Khajeh E, Neishaboury M. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes research and clinical practice. 2014 Feb 1; 103(2):319-27.
  6. Gomes MD. Impact of diabetes on cardiovascular disease: an update. International journal of hypertension. 2013 Mar 4; 2013.
  7. Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al: Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011, 364(9):829–841.
  8. Noori NM, Yazdanparast A, Teimouri A. The Correlation of Ferritin and Leptin Serum Levels with Cardiac Involvement in Thalassemia Patients Compared to Controls. International Journal of Pediatrics. 2018 May 1; 6(5):7623-38.
  9. Vergès B. Pathophysiology of diabetic dyslipidemia: where are we? Diabetologia. 2015 May 1; 58(5):886-99.
  10. M Abd-El Aziz F, Abdelghaffar S, M Hussien E, M Fattouh A. Evaluation of cardiac functions in children and adolescents with type I diabetes. Journal of cardiovascular ultrasound. 2017; 25(1):12-9.
  11. Noori N, Nakhaee Moghadam M, Razzaghian Pour M, Teimouri A, Bagheri H, Yazdanparast A. Tissue Doppler Imaging versus Conventional Echocardiography in Evaluation of Cardiac Functions in Diabetes Mellitus. International Journal of Pediatrics. 2019; 7(7):9677-91.
  12. Voulgari C, Papadogiannis D, Tentolouris N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag 2010; 6:883-903.
  13. Atabek ME, Kurtoglu S, Demir F, Baykara M. Relation of serum leptin and insulin‐like growth factor‐1 levels to intima‐media thickness and functions of common carotid artery in children and adolescents with type I diabetes. Acta Paediatrica. 2004 Aug; 93(8):1052-7.
  14. De Ferranti SD, De Boer IH, Fonseca V, Fox CS, Golden SH, Lavie CJ, Magge SN, Marx N, McGuire DK, Orchard TJ, Zinman B. Type I diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation. 2014 Sep
  15. Katz ML, Kollman CR, Dougher CE,Mubasher M, Laffel LMB. Influence of HbA1c and BMI on lipid trajectories in youths and young adults with type I diabetes. Diabetes Care 2017; 40: 30–37.23; 130(13):1110-30.
  16. Ozdemir O, Koksoy AY, Bulus AD, Andiran N, Yagli E. The effects of type I diabetes mellitus on cardiac functions in children: evaluation by conventional and tissue Doppler echocardiography. Journal of Pediatric Endocrinology and Metabolism. 2016 Dec 1; 29(12):1389-95.
  17. Mehravar F, Mansournia MA, Abolhassani M, Holakouie-Naieni K, Nasli-Esfahani E. The association between serum lipids profile and HbA1c in type 2 diabetes mellitus in Tehran, Iran. International Journal of Epidemiologic Research. 2017 Apr 1; 4(2):125-33.
  18. Mostofizadeh N, Hashemipour M, Roostazadeh M, Hashemi-Dehkordi E, Shahsanai A, Reisi M. The impact of poor glycemic control on lipid profile variables in children with type I diabetes mellitus. Journal of education and health promotion. 2019; 8.
  19. Rexhepi A, Jani Y, Pocesta B, Xhunga S, Serani A, et al. Effect of Uncontrolled Diabetic Dyslipidemia in the Prevalence of Sub-Clinic Left-Ventricular Diastolic Dysfunction in Western Region of the Republic of Macedonia. J Res Diabetes Metab. 2017; 3(1): 036-042.
  20. Otamere HO, Aloamaka CP, Okokhere PO, Adisa WA. Lipid Profile in Diabetes Mellitus; what impact has age and duration. British Journal of Pharmacology and Toxicology. 2011; 2 (3): 135-137.